Innovative drug development for headache disorders
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 0)

H-INDEX

(FIVE YEARS 0)

Published By Oxford University Press

9780199552764

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Discussion summary: Calcitonin gene-related peptide and 5-hydroxytryptamine modulators

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0017 ◽

2008 ◽

pp. 129-130

Author(s):

Rigmor Jensen

Keyword(s):

Calcitonin Gene Related Peptide ◽

Related Peptide ◽

Calcitonin Gene

Download Full-text

New 5-hydroxytryptamine-related drug targets

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0014 ◽

2008 ◽

pp. 109-114

Author(s):

Pramod R. Saxena

Keyword(s):

Drug Targets ◽

Related Drug

Download Full-text

Discussion summary: Nitric oxide and spreading depression modulators

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0012 ◽

2008 ◽

pp. 95-96

Author(s):

Nabih Ramadan

Keyword(s):

Nitric Oxide ◽

Spreading Depression

Download Full-text

Clinically relevant designs and outcome measures for acute migraine trials

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0006 ◽

2008 ◽

pp. 57-58

Author(s):

Michel D. Ferrari ◽

Hille Koppen

Keyword(s):

Outcome Measures ◽

Acute Migraine

Download Full-text

Stricter success criteria, qualitative and quantitative end-points: acute versus prevention trials

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0004 ◽

2008 ◽

pp. 31-42 ◽

Cited By ~ 1

Author(s):

Peer Tfelt-Hansen

Keyword(s):

End Points ◽

Qualitative And Quantitative ◽

Success Criteria ◽

Prevention Trials

Download Full-text

The human γ-aminobutyric acid transporter GAT-2: from cloning to high throughput screening

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0001 ◽

2008 ◽

pp. 3-16

Author(s):

Bolette Christiansen ◽

Trine Kvist ◽

Anders A. Jensen ◽

Hans Bräuner-Osborne

Keyword(s):

High Throughput ◽

High Throughput Screening ◽

Aminobutyric Acid ◽

Acid Transporter

Download Full-text

Future targets for headache therapy: prostanoids

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0024 ◽

2008 ◽

pp. 205-218

Author(s):

Christian Waeber

Keyword(s):

Headache Therapy

Download Full-text

The modulation of TRPV1 channels by cannabinoid1 receptors

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0023 ◽

2008 ◽

pp. 195-204

Author(s):

Beatriz Fioravanti ◽

Todd W. Vanderah

Keyword(s):

Trpv1 Channels

Download Full-text

Tonabersat

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0011 ◽

2008 ◽

pp. 85-94

Author(s):

Peter R. Blower ◽

Paul C. Sharpe

Download Full-text

Effectiveness of different steroid dosage in Tolosa–Hunt syndrome with different phenotypes: some critical points about the new International Headache Society classification

Innovative drug development for headache disorders ◽

10.1093/med/9780199552764.003.0007 ◽

2008 ◽

pp. 59-62

Author(s):

E. Marchioni ◽

S. Colnaghi ◽

M. Versino ◽

A. Pichiecchio ◽

E. Tavazzi ◽

...

Keyword(s):

Critical Points ◽

International Headache Society ◽

Hunt Syndrome ◽

Steroid Dosage ◽

International Headache Society Classification

Download Full-text

Innovative drug development for headache disordersLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Oxford University Press

Discussion summary: Calcitonin gene-related peptide and 5-hydroxytryptamine modulators

New 5-hydroxytryptamine-related drug targets

Discussion summary: Nitric oxide and spreading depression modulators

Clinically relevant designs and outcome measures for acute migraine trials

Stricter success criteria, qualitative and quantitative end-points: acute versus prevention trials

The human γ-aminobutyric acid transporter GAT-2: from cloning to high throughput screening

Future targets for headache therapy: prostanoids

The modulation of TRPV1 channels by cannabinoid1 receptors

Tonabersat

Effectiveness of different steroid dosage in Tolosa–Hunt syndrome with different phenotypes: some critical points about the new International Headache Society classification

Innovative drug development for headache disorders
Latest Publications